Correlation Between Icosavax and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Icosavax and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Icosavax and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Pmv Pharmaceuticals.
Diversification Opportunities for Icosavax and Pmv Pharmaceuticals
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Icosavax and Pmv is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Icosavax i.e., Icosavax and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Icosavax and Pmv Pharmaceuticals
If you would invest 158.00 in Pmv Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 2.00 from holding Pmv Pharmaceuticals or generate 1.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Icosavax vs. Pmv Pharmaceuticals
Performance |
Timeline |
Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pmv Pharmaceuticals |
Icosavax and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Icosavax and Pmv Pharmaceuticals
The main advantage of trading using opposite Icosavax and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |